Astrana Health Cash on Hand 2016-2026 | ASTH
Astrana Health cash on hand from 2016 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Astrana Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $429 |
| 2024 | $291 |
| 2023 | $296 |
| 2022 | $294 |
| 2021 | $287 |
| 2020 | $261 |
| 2019 | $220 |
| 2018 | $108 |
| 2017 | $119 |
| 2017 | $9 |
| 2016 | $57 |
| 2016 | $9 |
| 2015 | $1 |
| 2015 | $5 |
| 2014 | $5 |
|
Astrana Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-12-31 | $429 |
| 2025-09-30 | $463 |
| 2025-06-30 | $342 |
| 2025-03-31 | $261 |
| 2024-12-31 | $291 |
| 2024-09-30 | $350 |
| 2024-06-30 | $328 |
| 2024-03-31 | $337 |
| 2023-12-31 | $296 |
| 2023-09-30 | $277 |
| 2023-06-30 | $298 |
| 2023-03-31 | $279 |
| 2022-12-31 | $294 |
| 2022-09-30 | $217 |
| 2022-06-30 | $274 |
| 2022-03-31 | $281 |
| 2021-12-31 | $287 |
| 2021-09-30 | $333 |
| 2021-06-30 | $364 |
| 2021-03-31 | $273 |
| 2020-12-31 | $261 |
| 2020-09-30 | $284 |
| 2020-06-30 | $270 |
| 2020-03-31 | $198 |
| 2019-12-31 | $220 |
| 2019-09-30 | $231 |
| 2019-06-30 | $57 |
| 2019-03-31 | $94 |
| 2018-12-31 | $108 |
| 2018-09-30 | $129 |
| 2018-06-30 | $112 |
| 2018-03-31 | $124 |
| 2017-12-31 | $119 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | $9 |
| 2016-12-31 | $57 |
| 2016-03-31 | $9 |
| 2015-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |